RU2011147201A - Регероматические и ароматические пиперазинил ацетидинил амиды как моноцилглицероловые ингибиторы липазы - Google Patents
Регероматические и ароматические пиперазинил ацетидинил амиды как моноцилглицероловые ингибиторы липазы Download PDFInfo
- Publication number
- RU2011147201A RU2011147201A RU2011147201/15A RU2011147201A RU2011147201A RU 2011147201 A RU2011147201 A RU 2011147201A RU 2011147201/15 A RU2011147201/15 A RU 2011147201/15A RU 2011147201 A RU2011147201 A RU 2011147201A RU 2011147201 A RU2011147201 A RU 2011147201A
- Authority
- RU
- Russia
- Prior art keywords
- compound
- xyz
- isobutyl
- cyclohexylmethyl
- phenoxymethyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17166109P | 2009-04-22 | 2009-04-22 | |
US61/171,661 | 2009-04-22 | ||
PCT/US2010/032100 WO2010124122A1 (fr) | 2009-04-22 | 2010-04-22 | Pipérazinyl azétidinyl amides hétéroaromatiques et aromatiques en tant qu'inhibiteurs de la monoacylglycérol lipase |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2011147201A true RU2011147201A (ru) | 2013-05-27 |
Family
ID=42226535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011147201/15A RU2011147201A (ru) | 2009-04-22 | 2010-04-22 | Регероматические и ароматические пиперазинил ацетидинил амиды как моноцилглицероловые ингибиторы липазы |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2421535A1 (fr) |
JP (1) | JP2012524810A (fr) |
KR (1) | KR20120005517A (fr) |
CN (1) | CN102458407B (fr) |
AU (1) | AU2010238746B2 (fr) |
BR (1) | BRPI1014874A2 (fr) |
CA (1) | CA2759706A1 (fr) |
IL (1) | IL215797A0 (fr) |
RU (1) | RU2011147201A (fr) |
TW (1) | TW201103914A (fr) |
WO (1) | WO2010124122A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2760450A1 (fr) * | 2011-09-30 | 2014-08-06 | Janssen Pharmaceutica, N.V. | Inhibiteurs de monoacylglycérol lipase pour le traitement de maladies métaboliques et de troubles apparentés |
EP2935294A4 (fr) | 2012-12-21 | 2016-08-31 | Univ California | Méthodes et compositions pour le traitement de la toxicité du cyanure et de sulfure d'hydrogène |
JP6454349B2 (ja) * | 2013-12-26 | 2019-01-16 | 武田薬品工業株式会社 | モノアシルグリセロールリパーゼ(magl)阻害剤としての4−(ピペラジン−1−イル)−ピロリジン−2−オン化合物 |
WO2016158956A1 (fr) * | 2015-03-30 | 2016-10-06 | 武田薬品工業株式会社 | Composé hétérocyclique |
US10463753B2 (en) | 2016-02-19 | 2019-11-05 | Lundbeck La Jolla Research Center, Inc. | Radiolabeled monoacylglycerol lipase occupancy probe |
BR112018068538B1 (pt) | 2016-03-31 | 2023-12-12 | Takeda Pharmaceutical Company Limited | Composto, medicamento, e, uso de um composto |
WO2017170830A1 (fr) | 2016-03-31 | 2017-10-05 | 武田薬品工業株式会社 | Composé hétérocyclique |
MX2020007318A (es) | 2017-09-29 | 2020-08-24 | Takeda Pharmaceuticals Co | Compuesto heterociclico. |
EP3717477B1 (fr) | 2017-11-28 | 2022-07-20 | F. Hoffmann-La Roche AG | Nouveaux composés hétérocycliques |
TW201930300A (zh) * | 2017-12-15 | 2019-08-01 | 瑞士商赫孚孟拉羅股份公司 | 新雜環化合物 |
EP3856178A1 (fr) * | 2018-09-28 | 2021-08-04 | Janssen Pharmaceutica NV | Modulateurs de la monoacylglycérol lipase |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2915199B1 (fr) * | 2007-04-18 | 2010-01-22 | Sanofi Aventis | Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique. |
EP2180048B1 (fr) * | 2008-10-09 | 2014-12-17 | Janssen Pharmaceutica N.V. | Forme cristalline alternative de la monoacylglycérol lipase (MGLL) |
-
2010
- 2010-04-22 TW TW099112745A patent/TW201103914A/zh unknown
- 2010-04-22 AU AU2010238746A patent/AU2010238746B2/en not_active Ceased
- 2010-04-22 KR KR1020117027431A patent/KR20120005517A/ko not_active Application Discontinuation
- 2010-04-22 BR BRPI1014874A patent/BRPI1014874A2/pt active Search and Examination
- 2010-04-22 CA CA2759706A patent/CA2759706A1/fr not_active Abandoned
- 2010-04-22 CN CN201080028761.8A patent/CN102458407B/zh not_active Expired - Fee Related
- 2010-04-22 RU RU2011147201/15A patent/RU2011147201A/ru not_active Application Discontinuation
- 2010-04-22 WO PCT/US2010/032100 patent/WO2010124122A1/fr active Application Filing
- 2010-04-22 JP JP2012507395A patent/JP2012524810A/ja active Pending
- 2010-04-22 EP EP10714829A patent/EP2421535A1/fr not_active Withdrawn
-
2011
- 2011-10-23 IL IL215797A patent/IL215797A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN102458407B (zh) | 2014-03-05 |
KR20120005517A (ko) | 2012-01-16 |
AU2010238746B2 (en) | 2015-02-19 |
WO2010124122A1 (fr) | 2010-10-28 |
CN102458407A (zh) | 2012-05-16 |
IL215797A0 (en) | 2012-01-31 |
JP2012524810A (ja) | 2012-10-18 |
BRPI1014874A2 (pt) | 2016-04-12 |
CA2759706A1 (fr) | 2010-10-28 |
AU2010238746A1 (en) | 2011-11-10 |
EP2421535A1 (fr) | 2012-02-29 |
TW201103914A (en) | 2011-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2011147201A (ru) | Регероматические и ароматические пиперазинил ацетидинил амиды как моноцилглицероловые ингибиторы липазы | |
MX360289B (es) | Composiciones de tapentadol. | |
RU2010144637A (ru) | Замещенные гамма-лактамы в качестве терапевтических агентов | |
RU2010145459A (ru) | Ингибиторы активности протеинтирозинкиназы | |
RU2015111229A (ru) | Кристаллические формы гидрохлорида финголимода | |
RU2009145541A (ru) | Терапевтические соединения | |
RU2011129222A (ru) | Гемифумаратная соль 1-[4-[1-(4-циклогексил-3-трифторметилбензилоксиимино)этил]-2-этилбензил] азетидин-3-карбоновой кислоты | |
RU2011112444A (ru) | Фармацевтическая комбинация | |
MA33076B1 (fr) | Utilisation d'un inhibiteur de la gamma-secretase pour le traitement du cancer | |
RU2012127770A (ru) | Полициклические соединения и способы их применения | |
JP2003502308A5 (fr) | ||
DK1933833T3 (da) | Terapi til behandling af overaktiv blære | |
EA200802412A1 (ru) | Терапевтические комбинации для сопровождающихся болью медицинских состояний | |
RU2011123365A (ru) | Соли финголимода | |
RU2009112496A (ru) | Аминометил-4-имидазолы | |
JP2010526827A5 (fr) | ||
RU2008146816A (ru) | Фармацевтическая комбинация, содержащая 3-(3-диметиламино-1-этил-2-метилпропил)фенол и парацетамол | |
WO2009015485A8 (fr) | Inhibiteurs cycliques de la carnitine palmitoyltransférase et traitement anticancéreux | |
RU2015104097A (ru) | Соединения мочевины и их применение в качестве ингибиторов ферментов | |
HK1141019A1 (en) | Carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound | |
CA2606353A1 (fr) | Derives d'acides amines alpha-methyles | |
RU2012124332A (ru) | Соли азилсартана с органическими аминами, способ их получения и применение | |
RU2013156939A (ru) | Способ лечения лихорадки денге | |
EA201070603A1 (ru) | Лекарственное средство, активное в отношении невропатической боли | |
RU2008101776A (ru) | Соединения для ингибирования обратного захвата 5-гидрокситриптамина и норэпинефрина или для лечения депрессивных состояний, способы их получения и применения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20150414 |